Join
Live feed
·
INSIDERFilingvia Quantisnow
LB Pharmaceuticals Inc logo

Large owner Deep Track Biotechnology Master Fund, Ltd. converted options into 686,138 shares and bought $39,999,990 worth of shares (2,666,666 units at $15.00) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LBRX· LB Pharmaceuticals Inc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LBRX (LB Pharmaceuticals Inc) and more on Quantisnow.